CBD of Denver, Inc. (CBDD)
Stock analysis · OTC · Healthcare · Drug Manufacturers - Specialty & Generic
$0.00
Market Cap
$1.07M
PE (TTM)
-5.10
EPS (TTM)
N/A
Dividend Yield
0.00%
Beta
-8.68
Day Range
$0.00 – $0.00
52-wk Range
$0.00 – $0.00
Avg Volume
N/A
Volume
3.17M
CBD of Denver, Inc. (CBDD) is a publicly traded company in the Healthcare sector. Latest price: $0.00. Market cap $1.07M. Trailing PE -5.10. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About CBD of Denver, Inc.
CBD of Denver, Inc. engages in the cultivation, production, and distribution of cannabis flower and CBD products in Switzerland, Europe, and the US. Its brands include CBD Social Network, Black Peal CBD, and Rockflowr. The company was founded in 1993 and is headquartered in Centennial, CO.
Valuation
| P/E (TTM) | -5.10× |
|---|---|
| P/S (TTM) | 25.38× |
| P/B | -0.82× |
| P/FCF (TTM) | -59.15× |
| EV / EBITDA | -66.18× |
| EV / Sales | 48.32× |
| Earnings Yield | -19.60% |
| Free Cash Flow Yield | -1.69% |
Fundamentals
| Enterprise Value | $2.05M |
|---|---|
| Revenue (TTM) | $42.33K |
| Net Income (TTM) | -$210.49K |
| Free Cash Flow (TTM) | $378.52K |
| Net Debt | $971.13K |
| Working Capital | -$1.36M |
| Gross Margin | 5.17% |
| Operating Margin | -73.02% |
| Net Margin | -514.07% |
| Return on Equity | 16.01% |
| Return on Invested Capital | 8.14% |
Peers
Recent News
Related
Browse more tickers: sitemap